Peptimer technology (Peptimmune)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePeptimer technology (Peptimmune)
Drug Alias NameHIV vaccine (Peptimmune)p24 antigen therapy (Peptimmune)
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Antigen
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesVirus DiseasesHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPeptimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesVirus DiseasesHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A